-
Something wrong with this record ?
Translation of bi-directional transcripts enhances MHC-I peptide diversity
F. Zavadil, T. Henek, J. Habault, R. Chemali, MC. Tovar-Fernandez, C. Daskalogianni, L. Malbert-Colas, L. Wang, SV. Gnanasundram, B. Vojtesek, L. Hernychova, S. Apcher, R. Fahraeus
Language English
Document type Journal Article
NLK
Directory of Open Access Journals
from 2010
Free Medical Journals
from 2010
PubMed Central
from 2010
Europe PubMed Central
from 2010
Open Access Digital Library
from 2010-01-01
Open Access Digital Library
from 2010-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2010
- MeSH
- Lymphocyte Activation immunology MeSH
- RNA, Antisense * genetics immunology MeSH
- CD8-Positive T-Lymphocytes * immunology MeSH
- Leukocytes, Mononuclear immunology MeSH
- Humans MeSH
- Histocompatibility Antigens Class I * immunology genetics MeSH
- Peptides * immunology genetics MeSH
- Antigen Presentation MeSH
- Protein Biosynthesis * MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
Antisense transcripts play an important role in generating regulatory non-coding RNAs but whether these transcripts are also translated to generate functional peptides remains poorly understood. In this study, RNA sequencing and six-frame database generation were combined with mass spectrometry analysis of peptides isolated from polysomes to identify Nascent Pioneer Translation Products (Na-PTPs) originating from alternative reading frames of bi-directional transcripts. Two Na-PTP originating peptides derived from antisense strands stimulated CD8+ T cell proliferation when presented to peripheral blood mononuclear cells (PBMCs) from nine healthy donors. Importantly, an antigenic peptide derived from the reverse strand of two cDNA constructs was presented on MHC-I molecules and induced CD8+ T cell activation. The results demonstrate that three-frame translation of bi-directional transcripts generates antigenic peptide substrates for the immune system. This discovery holds significance for understanding the origin of self-discriminating peptide substrates for the major histocompatibility class I (MHC-I) pathway and for enhancing immune-based therapies against infected or transformed cells.
Department of Medical Biosciences Umeå University Umeå Sweden
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25016351
- 003
- CZ-PrNML
- 005
- 20250731092842.0
- 007
- ta
- 008
- 250708e20250317sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3389/fimmu.2025.1554561 $2 doi
- 035 __
- $a (PubMed)40165968
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a x
- 100 1_
- $a Zavadil, Filip $u RECAMO, Masaryk Memorial Cancer Institute, Brno, Czechia
- 245 10
- $a Translation of bi-directional transcripts enhances MHC-I peptide diversity / $c F. Zavadil, T. Henek, J. Habault, R. Chemali, MC. Tovar-Fernandez, C. Daskalogianni, L. Malbert-Colas, L. Wang, SV. Gnanasundram, B. Vojtesek, L. Hernychova, S. Apcher, R. Fahraeus
- 520 9_
- $a Antisense transcripts play an important role in generating regulatory non-coding RNAs but whether these transcripts are also translated to generate functional peptides remains poorly understood. In this study, RNA sequencing and six-frame database generation were combined with mass spectrometry analysis of peptides isolated from polysomes to identify Nascent Pioneer Translation Products (Na-PTPs) originating from alternative reading frames of bi-directional transcripts. Two Na-PTP originating peptides derived from antisense strands stimulated CD8+ T cell proliferation when presented to peripheral blood mononuclear cells (PBMCs) from nine healthy donors. Importantly, an antigenic peptide derived from the reverse strand of two cDNA constructs was presented on MHC-I molecules and induced CD8+ T cell activation. The results demonstrate that three-frame translation of bi-directional transcripts generates antigenic peptide substrates for the immune system. This discovery holds significance for understanding the origin of self-discriminating peptide substrates for the major histocompatibility class I (MHC-I) pathway and for enhancing immune-based therapies against infected or transformed cells.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a MHC antigeny I. třídy $x imunologie $x genetika $7 D015395
- 650 12
- $a CD8-pozitivní T-lymfocyty $x imunologie $7 D018414
- 650 12
- $a peptidy $x imunologie $x genetika $7 D010455
- 650 12
- $a proteosyntéza $7 D014176
- 650 _2
- $a aktivace lymfocytů $x imunologie $7 D008213
- 650 _2
- $a leukocyty mononukleární $x imunologie $7 D007963
- 650 _2
- $a prezentace antigenu $7 D017951
- 650 12
- $a antisense RNA $x genetika $x imunologie $7 D016372
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Henek, Tomas $u RECAMO, Masaryk Memorial Cancer Institute, Brno, Czechia
- 700 1_
- $a Habault, Justine $u Inserm UMRS1131, Institut de Génétique Moléculaire, Université Paris Cité, Hôpital St. Louis, Paris, France
- 700 1_
- $a Chemali, René $u UMR 1015 Immunologie des tumeurs et immunothérapie contre le cancer, B2M, Gustave Roussy, Université Paris Sud, Villejuif, France
- 700 1_
- $a Tovar-Fernandez, Maria Camila $u Inserm UMRS1131, Institut de Génétique Moléculaire, Université Paris Cité, Hôpital St. Louis, Paris, France
- 700 1_
- $a Daskalogianni, Chrysoula $u Inserm UMRS1131, Institut de Génétique Moléculaire, Université Paris Cité, Hôpital St. Louis, Paris, France
- 700 1_
- $a Malbert-Colas, Laurence $u Inserm UMRS1131, Institut de Génétique Moléculaire, Université Paris Cité, Hôpital St. Louis, Paris, France
- 700 1_
- $a Wang, Lixiao $u Department of Medical Biosciences, Umeå University, Umeå, Sweden
- 700 1_
- $a Gnanasundram, Sivakumar Vadivel $u Department of Medical Biosciences, Umeå University, Umeå, Sweden
- 700 1_
- $a Vojtesek, Borek $u RECAMO, Masaryk Memorial Cancer Institute, Brno, Czechia $u Laboratory of Growth Regulators, Institute of Experimental Botany, The Czech Academy of Sciences, Olomouc, Czechia
- 700 1_
- $a Hernychova, Lenka $u RECAMO, Masaryk Memorial Cancer Institute, Brno, Czechia
- 700 1_
- $a Apcher, Sebastien $u UMR 1015 Immunologie des tumeurs et immunothérapie contre le cancer, B2M, Gustave Roussy, Université Paris Sud, Villejuif, France
- 700 1_
- $a Fahraeus, Robin $u RECAMO, Masaryk Memorial Cancer Institute, Brno, Czechia $u Inserm UMRS1131, Institut de Génétique Moléculaire, Université Paris Cité, Hôpital St. Louis, Paris, France $u UMR 1015 Immunologie des tumeurs et immunothérapie contre le cancer, B2M, Gustave Roussy, Université Paris Sud, Villejuif, France $u Department of Medical Biosciences, Umeå University, Umeå, Sweden $u Laboratory of Growth Regulators, Institute of Experimental Botany, The Czech Academy of Sciences, Olomouc, Czechia
- 773 0_
- $w MED00181405 $t Frontiers in immunology $x 1664-3224 $g Roč. 16 (20250317), s. 1554561
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/40165968 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250708 $b ABA008
- 991 __
- $a 20250731092836 $b ABA008
- 999 __
- $a ok $b bmc $g 2366898 $s 1253476
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 16 $c - $d 1554561 $e 20250317 $i 1664-3224 $m Frontiers in immunology $n Front Immunol $x MED00181405
- LZP __
- $a Pubmed-20250708